X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
bexarotene (428) 428
humans (299) 299
index medicus (223) 223
male (144) 144
female (142) 142
dermatology (117) 117
oncology (114) 114
animals (102) 102
middle aged (98) 98
t-cell lymphoma (96) 96
tetrahydronaphthalenes - therapeutic use (92) 92
cutaneous t-cell lymphoma (90) 90
tetrahydronaphthalenes - pharmacology (89) 89
mycosis fungoides (83) 83
retinoids (82) 82
aged (81) 81
skin neoplasms - drug therapy (81) 81
sezary-syndrome (78) 78
adult (75) 75
cancer (69) 69
oral bexarotene (68) 68
lymphoma, t-cell, cutaneous - drug therapy (67) 67
treatment outcome (66) 66
mice (65) 65
mycosis-fungoides (62) 62
trial (61) 61
skin neoplasms - pathology (59) 59
pharmacology & pharmacy (58) 58
tetrahydronaphthalenes - administration & dosage (56) 56
anticarcinogenic agents - therapeutic use (49) 49
tetrahydronaphthalenes - adverse effects (49) 49
therapy (49) 49
retinoid x receptors - agonists (48) 48
antineoplastic agents - therapeutic use (47) 47
t cells (45) 45
apoptosis (42) 42
chemistry, medicinal (40) 40
clinical-trial (39) 39
neurosciences (38) 38
anticarcinogenic agents - pharmacology (37) 37
mycosis fungoides - drug therapy (37) 37
expression (36) 36
aged, 80 and over (35) 35
cell line, tumor (35) 35
chemotherapy (35) 35
non-hodgkin's lymphomas (35) 35
sezary syndrome (35) 35
skin neoplasms - therapy (34) 34
lymphoma, t-cell, cutaneous - pathology (32) 32
retinoid x receptors (32) 32
antineoplastic combined chemotherapy protocols - therapeutic use (31) 31
article (31) 31
hematology (31) 31
neoplasm staging (31) 31
rxr (30) 30
care and treatment (29) 29
denileukin diftitox (29) 29
dose-response relationship, drug (29) 29
mycosis fungoides - pathology (29) 29
research (29) 29
retinoid x receptor (29) 29
retinoid-x-receptor (29) 29
alzheimer's disease (28) 28
sézary syndrome (28) 28
analysis (27) 27
rats (27) 27
retinoid x receptors - metabolism (27) 27
acid (26) 26
antineoplastic agents (26) 26
disease models, animal (26) 26
lymphomas (26) 26
activation (24) 24
alzheimers-disease (24) 24
anticarcinogenic agents - administration & dosage (24) 24
anticarcinogenic agents - adverse effects (24) 24
biochemistry & molecular biology (24) 24
phototherapy (24) 24
antimitotic agents (23) 23
inflammation (23) 23
medicine & public health (23) 23
phase-ii (23) 23
administration, oral (22) 22
apoptosis - drug effects (22) 22
nuclear receptors (22) 22
targretin (22) 22
ligands (21) 21
prevention (21) 21
reverse deficits (21) 21
rexinoids (21) 21
skin (21) 21
cell lung-cancer (20) 20
combination (20) 20
combined modality therapy (20) 20
drug therapy (20) 20
hematology, oncology and palliative medicine (20) 20
lgd1069 (20) 20
transgenic mice (20) 20
antineoplastic agents - pharmacology (19) 19
gene-expression (19) 19
mice, inbred c57bl (19) 19
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (498) 498
Spanish (17) 17
German (9) 9
French (8) 8
Polish (5) 5
Chinese (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


U.S. Pharmacist, ISSN 0148-4818, 03/2012, Volume 37, Issue 3, pp. 61 - 63
Journal Article
JOURNAL OF MEDICINAL CHEMISTRY, ISSN 0022-2623, 08/2017, Volume 60, Issue 16, pp. 7139 - 7145
The retinoid X receptor (RXR) partial agonist 1-[(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydronaphthalen-2-yl)amino]benzotriazole-5-carboxylic acid (1; CBt-PMN,... 
ARYLMAGNESIUM | CHEMISTRY, MEDICINAL | CARBONYLATION | MONOXIDE | BEXAROTENE | MICE
Journal Article
Journal of Neuroscience, ISSN 0270-6474, 06/2015, Volume 35, Issue 24, pp. 9173 - 9181
Journal Article
Journal Article
Journal Article
Journal Article
Molecular Neurobiology, ISSN 0893-7648, 12/2018, Volume 55, Issue 12, pp. 9043 - 9056
Retinoid X-receptors (RXRs) are members of the ligand-dependent transcription factor family of nuclear receptors that have gained recent research focus as... 
Neurology | Retinoid-X-receptor | Neurosciences | Bexarotene | TrkB | Biomedicine | Amyloid beta | Neurobiology | ER stress | Cell Biology | ALZHEIMERS-DISEASE | NEUROTROPHIC FACTOR | MEMORY DEFICITS | NEUROSCIENCES | HUMAN NEUROBLASTOMA | IN-VITRO | AMYLOID-BETA | MOUSE MODEL | THERAPEUTIC TARGETS | UP-REGULATION | BRAIN | Cell Survival - drug effects | Endoplasmic Reticulum Stress - drug effects | Apoptosis - drug effects | Bexarotene - pharmacology | Humans | Mice, Inbred C57BL | Alzheimer Disease - drug therapy | Male | Neuroprotection - drug effects | Neurotoxicity Syndromes - drug therapy | Alzheimer Disease - pathology | Up-Regulation - drug effects | Animals | Neurotoxicity Syndromes - pathology | Alzheimer Disease - metabolism | Amyloid beta-Peptides - metabolism | Cell Line, Tumor | Neurotoxicity Syndromes - metabolism | bcl-Associated Death Protein - metabolism | Bexarotene - therapeutic use | Receptor, trkB - metabolism | Retinoid X Receptors - metabolism | Disease Models, Animal | Proteins | Heat shock proteins | Nervous system diseases | Stress (Physiology) | Analysis | Apoptosis | Neuroprotection | Brain | Neurodegenerative diseases | Toxicity | Therapeutic applications | Glial cells | Retinoid X receptors | Nuclear receptors | Neuroblastoma cells | Stress | Western blotting | Signal transduction | Neurotoxicity | Isoforms | Bad protein | TrkB receptors | Immunofluorescence | Stress proteins | Endoplasmic reticulum | Index Medicus
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 07/2017, Volume 377, Issue 1, pp. 62 - 70
This review considers master protocols, which involve the study of one or more interventions in multiple diseases or of a single disease with multiple... 
MEDICINE, GENERAL & INTERNAL | PHASE-II | TRIAL DESIGN | ERA | ADAPTIVE RANDOMIZATION | CLINICAL-TRIALS | Disease | Research Design | Humans | Clinical Protocols | Therapeutics | Clinical Trials as Topic - organization & administration | Intervention | Clinical trials | Medical research | Protocol
Journal Article
Journal Article
Organic and Biomolecular Chemistry, ISSN 1477-0520, 04/2013, Volume 11, Issue 14, pp. 2348 - 2354
Journal Article
Journal of Neuroinflammation, ISSN 1742-2094, 02/2018, Volume 15, Issue 1, p. 43
Journal Article
Journal of Medicinal Chemistry, ISSN 0022-2623, 01/2013, Volume 56, Issue 2, pp. 388 - 405
Journal Article
Gulhane Medical Journal, ISSN 1302-0471, 2015, Volume 57, Issue 4, pp. 343 - 347
Journal Article